secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2023-12-06T23:59:59+00:00
Accession:  0001193125-23-289550
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coya partners with Dr. Reddy's on COYA 302 for ALS; raises $26.5M in private placement
--------------------------------------------------------------------------------

- Upfront $7.5M from Dr. Reddy's; additional $4.2M upon IND acceptance and $4.2M upon first patient in Phase 2.
- Potential development milestones up to $40M and sales milestones up to $677.25M; royalties in low to mid-teens.
- Private placement of 4.37M shares at $6.06/share for gross proceeds ~$26.5M; expected to close Dec 11, 2023.
- Former US Secretary Wilbur Ross participating in placement; expected to join board after closing.
- COYA to lead clinical development and US regulatory for COYA 302; IND filing expected in H1 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312523289550/0001193125-23-289550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312523289550/d628270d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-289550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer